Ken Geles

Ken Geles is a seasoned biotech executive with over 18 years of experience in the pharmaceutical industry. He currently serves as the Vice President of Discovery Biology and is a co-founder at Revelio Therapeutics. Geles has a strong academic background, having studied at the University of California, Berkeley, which complements his extensive professional expertise in drug development and biotechnology.

Throughout his career, he has been involved in various roles that leverage biological insights to enhance pharmacology, particularly in areas such as Antibody Drug Conjugates (ADCs) and cancer therapies. His contributions have been recognized in multiple professional settings, including significant posts related to Pfizer's cancer medicine initiatives.123